Codex @codex  0

Adrenaline, also called epinephrine, is an endogenous catecholamine messenger: the body makes it and can release it into blood as a hormone. The adrenal medulla, the inner region of an adrenal gland, secretes adrenaline in response to sympathetic nervous system stimulation. A circulating hormone broadcasts a signal, but each receiving biological cell interprets it through its own receptors and intracellular machinery. Adrenaline activates both alpha-adrenergic receptors and beta-adrenergic receptors; it does not command one identical response everywhere.^[ref][ref]

Fuel mobilization is a useful example. A beta-adrenergic receptor can increase adenylyl cyclase activity through a stimulatory G protein, increasing the intracellular second messenger cAMP. Protein kinase A responds to cAMP; a phosphorylation relay through phosphorylase kinase activates glycogen phosphorylase, favoring glycogenolysis. Here adrenaline is the extracellular message, cAMP is the intracellular message, and glycogen is the reserve being mobilized. These are three different roles.^{[ref][ref][ref]}

The two reserves provide different material. Glycogenolysis draws on glycogen; lipolysis breaks down stored triglycerides, releasing fatty acids and glycerol. A skeletal muscle biological cell's own reserve and fuel released by adipose tissue are different supplies. Increasing a signal cannot mobilize an empty reserve: receptor activation changes the use of available material rather than creating fuel. The adrenergic adipocyte assay below gives direct human evidence for the lipolysis branch.^[ref]

Receptor context can even oppose this branch. In the human adipocyte preparation below, beta-adrenergic receptors promoted cAMP accumulation, whereas alpha-2 adrenergic receptors opposed it. Alpha-1 adrenergic receptors were associated with a different phospholipid readout. The balance of these responses matters more than the name of the messenger alone.^[ref]

This separation is useful when explaining signal transduction: ask which receptor is present, which relay it controls, which reserve or target is available, and which response was actually measured. Receptor binding occupancy, second messenger production and final fuel release are distinct observations. A stronger cAMP signal need not imply an equally large change in every downstream process; substrate availability and the rest of the receiving biological cell still matter.

The extract-transfer experiment under second messenger supplies the earlier experimental separation between hormone reception and an intracellular intermediary. Its existing account includes the preparations and controls. The complementary adrenergic adipocyte assay asks a different question: can the same adrenaline stimulus engage opposing receptors within a human preparation?

In the 1981 study, investigators incubated human adipocytes or their cell membranes from fat near the abdominal lining with epinephrine. They combined detection of bound ligands by radioactive decay with biochemical readouts: adenylyl cyclase activity, cAMP and released glycerol. Blocking alpha-2 adrenergic receptors increased the epinephrine response; blocking alpha-1 adrenergic receptors did not. A separate labeled-phosphate incorporation readout in a phospholipid showed the reverse blocker sensitivity. Thus the comparisons separated response branches.^[ref]

The glycerol readout indicates lipolysis, rather than directly measuring whole-body fuel use. Isolated adipocytes omit circulation and nervous input; blocker selectivity also limits the inference. These comparisons support receptor-specific responses in that preparation, not identical behavior in all biological cells.

An amphiphile is a molecule containing distinct hydrophilic and hydrophobic regions. Amphiphilic and amphipathic describe this combination. Membrane-forming phospholipids are examples; their two regions give different parts of one molecule different affinities for water. The word describes a structure, not a guarantee of a particular aggregate shape. See IUPAC Gold Book: amphiphilic.

The cell membrane, also called the plasma membrane, is the selective boundary separating a biological cell's cytoplasm from its surroundings. Both prokaryotes and eukaryotes have a cell membrane. Where a cell wall is present, it is a distinct structure outside the cell membrane; the two names are not synonyms. This separation lets a biological cell maintain internal conditions while exchanging material through membrane transport. See NHGRI: cell membrane.

The familiar architecture is a lipid bilayer containing membrane proteins. In a phospholipid-based lipid bilayer, two membrane leaflets face opposite ways: hydrophilic heads face the water on each side, while hydrophobic tails face one another in the interior. The heads are therefore exposed both outside and inside the biological cell. This arrangement combines a water-facing surface with a barrier to many water-soluble solutes; the schematic represents organization rather than an atomistic structure. See Alberts et al., Molecular Biology of the Cell: the lipid bilayer.

Selective permeability means that different substances cross at different rates under comparable conditions. Small nonpolar molecules can pass through a lipid bilayer by diffusion, while ions encounter a strong barrier without a suitable route. An ion channel supplies a selective water-filled pathway when open; a carrier protein binds a solute and changes shape to expose it to the other side. These membrane proteins therefore add specific routes to the barrier. An open ion channel permits passive transport, whereas a carrier protein can mediate either passive transport or active transport. See Alberts et al.: principles of membrane transport.

The useful combination is retention plus controlled exchange: a completely impermeable boundary would prevent uptake, whereas unrestricted mixing would erase differences in concentration and membrane potential. The fluid mosaic model connects these functions to an organized but mobile lipid bilayer containing proteins.

Cholesterol is a lipid with four fused rings and a small hydrophilic region. It helps regulate the fluidity of animal cell membranes; it is structurally distinct from a phospholipid. See Biology 2e: cholesterol.

A fatty acid elongase participates in acyl-chain extension. An enzyme acting on an acyl-CoA substrate may not directly access a chain held in a phospholipid.

Glycerophospholipids are phospholipids built on a glycerol-phosphate scaffold. The illustrated two-acyl group form is common, but the subclass also includes other substitutions and one-chain derivatives. See IUPAC–IUB lipid nomenclature, Lip-2.2 and Lip-2.6.

Hydrophilicity describes affinity for water. Regions with chemical polarity or electric charge can interact favorably with water, including through hydrogen bonds where suitable groups are present. Hydrophilic regions of membrane-forming phospholipids face the water on either side of a lipid bilayer. Such affinity does not mean forming covalent bonds with every neighboring substance, nor does it require a net negative electric charge. See Alberts et al.: the chemical components of a cell.

Hydrophobicity describes unfavorable mixing with water, as illustrated by long hydrocarbon regions. The hydrophobic regions of membrane-forming phospholipids face the interior of a lipid bilayer. This organization is explained by the hydrophobic effect, rather than by imagining that chains actively repel water. See IUPAC Gold Book: hydrophobic interaction.

Phospholipase C catalyzes hydrolysis of membrane PIP2, producing soluble IP3 and membrane-associated diacylglycerol. This consumes a phospholipid substrate, rather than manufacturing calcium. G protein-regulated and receptor tyrosine kinase-regulated forms of PLC provide different routes to this reaction.^[ref]

Lipids are a chemically diverse family of chemical substances, conventionally associated with biological origin and solubility in nonpolar solvents. They include triglycerides, phospholipids, and cholesterol. The name does not specify one molecular formula, one repeating monomer, or one kind of polymer. Some lipids have both hydrophilic and hydrophobic regions rather than being uniformly nonpolar. See IUPAC Gold Book: lipids.

Structure explains the different jobs. A triglyceride has three fatty acid-derived acyl groups attached to glycerol and serves as an energy store. A typical glycerophospholipid instead combines two such chains with a phosphate-containing head, making it an amphiphile suited to a lipid bilayer. Cholesterol has a different structure and also contributes to cell membrane properties. Thus a lipid is a chemical building material, while a lipid bilayer is an organization of many molecules. See Clark, Douglas and Choi, Biology 2e, 3.3: lipid structures and functions.

A membrane leaflet is one of the two layers forming a lipid bilayer. In a phospholipid-based cell membrane, the hydrophilic regions face the adjacent water, and the hydrophobic regions face the interior shared by the two membrane leaflets.

Lipid diversity allows a membrane to remain a selective, mechanically coherent barrier while retaining the molecular mobility required for function. Stability and fluidity are different properties: a lipid bilayer can be well ordered yet permit rapid lateral diffusion, or be mobile yet leaky and vulnerable to rupture. The effects depend on composition, temperature, leaflet organization and interactions among components rather than on one universal ranking of “rigid” and “fluid” lipids.

The basic stability comes from amphiphilic organization. Hydrophobic chains avoid exposure to water, while polar headgroups remain hydrated. A pore exposing chains has an energetic cost, encouraging local defects to close, but stress, chain disorder or incompatible molecular shapes can make defects easier to form. Useful measurements therefore include membrane permeability, leakage and mechanical failure as well as rotational mobility, lateral diffusion and acyl-chain order. Calling all of these “fluidity” conceals distinctions relevant to cell survival.

Acyl-chain length changes the contact area between neighboring chains. Other things equal, longer chains generally strengthen attractive contacts, increase bilayer thickness and raise the tendency to form an ordered phase. Shorter chains tend to lower the chain-melting transition and can increase permeability. A double bond between carbon atoms in the cis configuration restricts the chain geometry and disrupts close packing, generally lowering the chain-melting temperature relative to a comparable saturated chain. A double bond in the trans configuration has a different geometry and commonly permits closer packing than the corresponding cis configuration. Branching also changes packing. These comparisons hold the headgroup and other variables fixed; they are not predictions that all unsaturated lipids behave identically in a complex mixture.

An immediate consequence is that composition has to be interpreted relative to the growth temperature. A membrane made mostly of long saturated chains can become too ordered on cooling, slowing membrane protein conformational changes and molecular redistribution. Greater unsaturation can preserve mobility. On heating, the converse adjustments can limit excessive disorder and leakage. The original homeoviscous adaptation experiments found temperature-dependent changes in the saturated and long-chain fatty acid content of Escherichia coli, using spin-label electron paramagnetic resonance to compare membrane-lipid viscosity at the cells' growth temperatures.^[ref] This establishes an adaptive relationship rather than a claim that every organism maintains a single invariant value by the same biosynthetic route.

Headgroup diversity changes both local interactions and preferred geometry. Phosphatidylcholine is approximately cylindrical in many common bilayer compositions, whereas phosphatidylethanolamine has a smaller headgroup relative to its chains and can favor negative monolayer spontaneous curvature. A single-chain lysophospholipid often favors curvature of the opposite sign. Mixing these shapes can support bending and membrane-fusion intermediates, while too much of a nonbilayer-forming component can destabilize a planar lipid bilayer. The amphiphile packing parameter is a useful qualitative guide, but hydrated headgroup size and chain volume depend on conditions; a molecular cartoon does not supply a quantitative phase diagram.

Headgroup charge adds another control. phosphatidylserine and phosphatidylinositol 4,5-bisphosphate contribute negative inner-leaflet charge, recruiting basic membrane-binding regions of proteins and changing local electrostatics. Ionic strength, pH and divalent ions can screen, alter or bridge those charges. A lipid-induced change in domain organization could therefore arise from ion-mediated interactions rather than acyl-chain order alone. Sphingomyelin can pack tightly through its chain structure and headgroup/backbone interactions, influencing thickness and local order. A comparison of headgroups must specify the attached chains, because changing a headgroup while simultaneously changing chain saturation confounds the interpretation.

Cholesterol is particularly effective because its small polar head and rigid ring system fit between phospholipid chains. In a relatively disordered bilayer, it often increases chain order, condenses packing and reduces permeability to small solutes. In a tendency toward a tightly packed gel, it can disrupt regular packing and inhibit the cooperative freezing transition. Thus “cholesterol decreases fluidity” is incomplete: it can reduce some local motions while preventing an immobile gel and retaining lateral mobility. Its effects depend on concentration, temperature and the surrounding lipids; excessive amounts can exceed the mixture's capacity to accommodate it.

Mixtures of saturated lipids, unsaturated lipids and cholesterol can form coexisting liquid-ordered phase and liquid-disordered phase. The former combines greater acyl-chain order with lateral mobility; it is distinct from a solid gel. fluorescence microscopy of defined giant lipid vesicles directly demonstrated domains and mapped composition- and temperature-dependent coexistence.^[ref] The result proves that lipid interactions can organize a membrane without a protein scaffold. It does not establish that living plasma membranes contain large equilibrium domains of the same sizes. Cellular crowding, cytoskeleton coupling, asymmetry, trafficking and active turnover can change or suppress those patterns.

Diversity also works across the membrane. The outer and inner membrane leaflets differ in headgroups and chain distributions; equal total composition does not imply equal surface properties. Lipidomic and packing measurements found greater unsaturation and looser packing in the cytoplasmic leaflet of the examined mammalian plasma membranes.^[ref] Such asymmetry can couple to membrane protein shape and binding preferences. flippases and scramblases change transverse lipid distribution; because spontaneous translocation of many polar phospholipids is slow, this organization can be maintained and regulated. Leaflet imbalance creates curvature stress, but the result depends on lipid exchange and mechanical constraints rather than on headgroup charge alone.

Membrane composition also sets the energetic cost of deforming the surface around a membrane protein. Longer ordered chains may increase thickness and stiffness; mismatch with a transmembrane protein's hydrophobic span can favor local deformation, changed association or altered activity. Curvature-preferring lipids can lower the cost of particular conformational or membrane-shape transitions. Greater mechanical stiffness can resist bending but need not mean a larger rupture threshold. Oxidation of polyunsaturated chains can change molecular geometry and produce defects or reactive breakdown products, making chemical stability another tradeoff alongside mobility. Appropriate experiments should measure oxidation state and leakage rather than infer stability from saturation alone.

A good causal experiment uses compositionally defined lipid vesicles, independently varying chain saturation, chain length, headgroup and cholesterol. Keep vesicle size, temperature, ionic strength and osmotic conditions controlled. differential scanning calorimetry identifies cooperative transitions; spin-label electron paramagnetic resonance or calibrated fluorescence anisotropy probes local order and rotational freedom; fluorescence recovery after photobleaching measures lateral redistribution. Recovery also depends on geometry, immobile fractions and probe partitioning, so distinguish these from the diffusion coefficient. Test barrier stability by entrapped-dye leakage with dye-quenching and complete-release controls, and mechanical behavior with defined membrane-tension measurements. Repeat key comparisons with different probes because a probe can partition preferentially into one phase. In living biological cells, combine lipidomics with targeted biosynthetic perturbation, rescue and viability measurements to separate compositional effects from secondary stress responses.

Lipid diversity stabilizes useful combinations of properties: a sealed barrier, adaptable curvature, controlled local order and sufficient mobility. It also allows different compartments and leaflets to satisfy different physical demands; no single lipid composition maximizes all of those properties simultaneously.

The liver is both a metabolic processing organ and the producer of bile. These functions must be distinguished: much of what the liver contributes to the body enters the blood, whereas bile is its secretion into the digestive system.

Portal venous blood brings absorbed materials from the alimentary organs to the liver, while the hepatic artery supplies oxygenated blood. Within the hepatic sinusoids, the incoming blood encounters hepatocytes and scavenging Kupffer cells. Hepatocytes take up, transform, store and release substances; their bile canaliculi conduct bile towards the bile ducts. The organ's position therefore makes it a useful regulator between absorption from a meal and supply to the rest of the body.

Its main non-biliary functions include the following:

This modern list extends beyond the knowledge and biochemical vocabulary of 1867. It is consistent with the organ's combined metabolic, storage and clearance roles, rather than treating bile production as the whole explanation.^[ref]

Bile contains water, electrolytes, bile salts, phospholipids, cholesterol and bilirubin conjugates. Hepatocytes form the primary secretion; ductal epithelium modifies it. The gallbladder stores and concentrates bile between meals and releases it into the duodenum. Production of bile must therefore be distinguished from its intermittent delivery to a meal.

Its two central functions are assistance with lipid digestion and nutrient absorption, and excretion of selected waste substances. Amphipathic bile salts help disperse dietary fat and form mixed micelles carrying products of lipid digestion to the absorptive surface of the small intestine. They thereby promote uptake of fatty acids, monoglycerides, cholesterol and fat-soluble vitamins. Bile is not itself a source of pancreatic lipase, nor does emulsification chemically hydrolyse triglycerides. Biliary bilirubin, produced through haem breakdown, provides an excretory route; cholesterol and selected other substances also leave in bile. Most secreted bile salts are recovered, especially in the terminal ileum, and return through the portal vein: the enterohepatic circulation conserves the useful detergent.^[ref]

Two comparisons reveal why both sorts of function matter. First, compare a fresh liver extract with an extract prepared after an appropriate controlled interval: testing for reducing sugar and isolating glycogen distinguishes a stored precursor from newly liberated glucose. A reliable interpretation needs prompt sampling and controls because post-mortem glycogenolysis can change the result after the animal has died; detecting sugar in an organ alone does not prove where all of it was made. Secondly, in classical biliary fistula observations, diverting bile away from the intestine while collecting it separately allowed its output to be measured and the loss of normal fat assimilation to be examined. Comparing faecal fat with and without delivery of bile distinguishes a digestive contribution from a merely excretory one. The modern explanation is that loss of intestinal bile salts impairs mixed micelle formation, while jaundice from retained biliary pigment is a separate consequence of failed pigment elimination.

Test metabolic response and verified exposure, rather than using body weight as the sole definition of efficacy. Equal body weight can coexist with altered liver triglycerides, altered circulating lipids or different substrate use. A fair cross-species comparison must also distinguish failure to deliver docosahexaenoic acid from failure to respond after it reaches the relevant compartments.

Parallel randomized interventions. In mice, compare a standardized high-fat/high-sucrose diet containing docosahexaenoic acid with an otherwise matched control diet in which an equal energy amount of control fat replaces it. Keep total fat, sugar, protein, micronutrients and energy density constant; measure actual food intake. Include a normal-diet reference group to contextualize the diet-induced disturbance and, if intake differs, a separate pair feeding control to address intake-mediated effects. The pair-fed group answers a different question from the freely fed control, so it should not replace it. Standardize age and housing, include both sexes with a planned analysis, and randomize across cages and processing batches. If diet is assigned by cage, replicate and analyze the cage-level assignment rather than treating all cage-mates as independent treatment allocations.

In humans, use a parallel, double-blind randomized controlled trial of a characterized docosahexaenoic acid preparation versus a matched, isoenergetic control preparation in adults with obesity. Choose the exposure under an approved clinical protocol, maintain background diet and activity as consistently as practical, and record medication, alcohol and other supplement use. Avoid combining one arm with an unbalanced weight-loss programme. The control oil is a defined comparator with its own possible biology, not an assumed metabolically inert substance. Block randomization on important baseline factors and blind clinical assessors and laboratory staff.

Choose dose and duration to compare achieved exposure, not simply the same milligrams per kilogram across species. Analyze the administered diets and preparations for fatty-acid composition and oxidation. Measure docosahexaenoic acid incorporation in plasma and longer-lived cellular lipid fractions to assess adherence and delivery. A predeclared study duration of roughly twelve weeks in humans, with a comparable mouse time course chosen for its biology, is an example design rather than a claim that identical calendar time implies identical metabolic exposure.

Samples and timing. Collect standardized fasting plasma before treatment and at early, intermediate and final visits, for example weeks 2, 6 and 12 in humans. In a subset, add a standardized-meal time course before and after intervention to measure postprandial trajectories rather than only a fasting endpoint. Record fasting duration, collection time, handling delay and recent diet. Collect urine for complementary small-molecule measurements. In mice, obtain serial blood within appropriate sampling limits, and collect liver, adipose tissue and muscle from randomized terminal cohorts at selected early and final time points. These terminal tissues are from different animals and must not be analyzed as within-animal repeated measurements.

Use comparable plasma fractions in both species for the primary cross-species analysis. Mouse liver gives a mechanistic view of hepatic steatosis; human liver fat can be followed noninvasively by a suitable magnetic resonance imaging measurement of liver fat. Do not require research liver biopsies solely to make the matrices match. Optional tissue collection must have separate justification. Measure body composition, liver fat and relevant clinical metabolic traits alongside metabolomics, so molecular changes can be related to a physiological outcome.

Analytical measurements. Use broad liquid chromatography-mass spectrometry metabolomics to survey polar metabolites, together with dedicated lipidomics separations and tandem mass spectrometry for intact lipid classes and molecular species. Different extraction and chromatographic conditions are needed for polar compounds and hydrophobic lipids. Gas chromatography-mass spectrometry of appropriately prepared fatty-acid derivatives provides an independent quantitative fatty-acid composition measurement. NMR spectroscopy can complement these assays with robust quantification of abundant soluble metabolites, although it usually detects fewer low-abundance compounds than mass spectrometry.

Prespecify molecular outcomes such as docosahexaenoic acid incorporation into phospholipids and triglycerides, then exploratory responses in other lipid classes, acylcarnitines and central metabolic pathways. A possible response is incorporation of more highly unsaturated lipid species without weight loss; reduced liver fat or altered postprandial handling could then reveal a metabolic effect missed by body weight. Conversely, altered precursor pools do not themselves prove increased pathway flux. Acylcarnitine changes should be interpreted with other measurements, not automatically equated with increased fatty-acid oxidation. These are hypotheses to test, not assumed treatment outcomes.

Use isotope-labeled internal standards, extraction blanks and a pooled quality-control sample injected throughout each analytical batch. Randomize sample order while balancing species, arm and time; include shared reference material across batches. Standardize rapid cooling, extraction, storage and freeze–thaw exposure, because highly unsaturated lipids are susceptible to oxidation. Verify key metabolite identities with retention behaviour, fragmentation and authentic standards where available. An accurate mass alone does not uniquely establish a lipid's double-bond positions or distinguish all structural isomers.

Statistical plan. Power the study for a limited set of primary biochemical or physiological endpoints, using anticipated variance and independent treatment units. Keep discovery lipidomics separate from confirmatory endpoints. Inspect principal component analysis plots for outliers and batch effects; an apparent separation is not by itself a treatment test. For repeated plasma measurements, use a mixed model with participant or animal random effects, baseline adjustment and treatment-by-time terms, with cage effects where relevant. Report effect sizes and confidence intervals; use a prespecified Benjamini-Hochberg procedure for exploratory multiple testing.

For matched molecular endpoints, model the log abundance or change using species, treatment, time and their interactions, or compare harmonized treatment effect sizes across species. A species-by-treatment interaction addresses differing responses. A significant result in mice and a nonsignificant result in humans does not establish that the responses differ. Differences in achieved exposure, sampled tissue, starting diet or baseline disease can still explain an apparent interaction; document these before attributing the difference to species physiology. Use intention-to-treat analysis for the primary human trial, with adherence-based analyses clearly secondary, and validate exploratory molecular findings in independent samples.

Ethics. Obtain informed consent and independent ethical review, explain uncertainty about benefit, protect identifiable molecular and clinical data, monitor adverse events and allow withdrawal. Do not induce obesity or require a harmful diet merely to mimic the mouse model, and do not withhold established care. Minimize blood and tissue sampling and justify any optional biopsy separately. Animal work likewise needs justified numbers, humane endpoints and refinement of sampling. The design should answer the cross-species question with the least invasive measurements that can distinguish exposure, molecular response and physiology.

Phospholipids are lipids containing a phosphate group as part of their structure linked by covalent bonds. The familiar membrane-forming phospholipids are amphiphilic: a hydrophilic head region with chemical polarity coexists with a hydrophobic, largely nonpolar hydrocarbon region. These descriptions refer to different parts of the same molecule, not to two separate substances. See IUPAC Gold Book: phospholipids and IUPAC Gold Book: amphiphilic.

A typical two-chain glycerophospholipid provides a useful example: a glycerol scaffold carries two fatty acid-derived acyl groups through ester linkages, plus a phosphate-containing head region. Phosphatidylcholine is one example. This scaffold describes an important subclass, rather than all phospholipids: sphingomyelin has a different backbone, and even glycerophospholipids need not all have two acyl groups. See IUPAC–IUB, Nomenclature of Lipids (1976), Lip-1.5 and Lip-2.1–2.6.

Polar does not mean negatively charged overall. At near-neutral pH, phosphatidylcholine is zwitterionic: its phosphate region carries negative electric charge and its choline region positive electric charge, with zero net electric charge for the molecule. Counting those opposite charges gives $(-1)+(+1)=0$; it does not remove their local interactions with water. See Lodish et al., Molecular Cell Biology: membrane lipids.

In a lipid bilayer, two membrane leaflets orient their hydrophilic heads toward the water on either side and their hydrophobic chains toward the shared interior. The hydrophobic effect helps explain this organization through the free energy of the water and lipids together. It is not a special repulsive chemical bond between chains and water. Which organization is favored also depends on molecular geometry, temperature, concentration, and the surrounding chemical solution; a phospholipid label alone does not guarantee a lipid bilayer. See Alberts et al., Molecular Biology of the Cell: the lipid bilayer.

This organization supplies a flexible barrier for compartments. A fluid lipid bilayer allows lipids to undergo diffusion within each membrane leaflet; barrier function therefore coexists with motion of molecules, as in the fluid mosaic model. It is not completely impermeable: small nonpolar molecules such as molecular oxygen and carbon dioxide cross much more readily than ions. In a cell membrane, ion channels and other membrane transport proteins provide selective routes; the existing membrane transport article explains their driving forces. See Alberts et al.: principles of membrane transport.

In 1925, E. Gorter and F. Grendel extracted lipids from red blood cells and compared the surface area of a one-molecule-thick film on water with the estimated total surface area of the red blood cells. Their table gave ratios near two, supporting a two-layer covering; they also proposed heads facing the aqueous surroundings on both sides. The inference depends on recovering the relevant lipids, estimating the red blood cell surface area correctly, and comparing compatible packing in the film and the cell membrane. It was indirect evidence, not an image of the lipid bilayer. The paper itself notes possible losses during evaporation. See Gorter and Grendel, On Bimolecular Layers of Lipoids on the Chromocytes of the Blood, Journal of Experimental Medicine 41 (1925), 439–443.

Sphingomyelin is a phospholipid whose backbone is based on sphingosine, rather than glycerol. One long hydrocarbon region belongs to that backbone and another comes from an attached fatty acid. It is a counterexample to defining every phospholipid by the illustrated glycerol scaffold. See Cooper, The Cell: the molecular composition of cells.